Beqvez, a one-time gene therapy, offers hope to patients with moderate to severe hemophilia B who use regular factor IX ...

Approval update comes as a result of findings from Study 5310, which addressed Biktarvy’s pharmacokinetics, safety, and ...

In an interview with Pharm Exec Associate Editor Don Tracy, Howard Berman, Chairman, CEO, Coya Therapeutics offers a look at ...

In this Pharmaceutical Executive video interview, Amanda Powers-Han, Chief Marketing Officer, Greater Than One, discusses ...

CVS Health announced that it is opening a workforce development and community center in Louisiana. 1 The center will be ...

Genomic research and technology company BioAro announced that it is launching new software that is capable of real-time ...

Melton, customer advocacy executive at Magnolia, discusses how new technologies can be used to ensure data is accurate.

Pivya has shown efficacy against bacteria strains such as Escherichia coli, Proteus mirabilis, and Staphylococcus ...

In this Pharmaceutical Executive video interview, Amanda Powers-Han, Chief Marketing Officer, Greater Than One, discusses how ...

In an interview with Pharm Exec Associate Editor Don Tracy, Howard Berman, Chairman, CEO, Coya Therapeutics offers a preview ...

Ojemda is the first systemic therapy approved by the FDA for the treatment of relapsed or refractory pediatric low-grade ...

In this Pharmaceutical Executive video interview, Jon Hamrick, Partner, Curatio Scientia Advisors and Jon Rawlson, President ...